ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Enzyme Replacement Therapy (ERT) Drugs Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-21L17330
Home | Market Reports | Health| Medical Facilities & Services
Global Enzyme Replacement Therapy ERT Drugs Market Research Report 2024
BUY CHAPTERS

Global Enzyme Replacement Therapy (ERT) Drugs Market Research Report 2024

Code: QYRE-Auto-21L17330
Report
June 2024
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
ERT
Sanofi
Takeda
BioMarin
AbbVie
Alexion
Allergan plc
Horizon Pharma
Johnson & Johnson
Actelion Ltd
Recordati Rare Diseases
Pfizer Inc
Digestive Care
Leadiant Biosciences

Enzyme Replacement Therapy (ERT) Drugs Market

Enzyme replacement therapy (ERT) is a medical treatment whereby replacement enzymes are given to patients who suffer from chronic conditions resulting from enzyme deficiencies or malfunction. The most common method of ERT is through IV infusions, in which the replacement enzyme is administered directly into the bloodstream through a controlled drip of fluids. Replacement enzymes for ERT are derived from human, animal, and plant cells that are then genetically modified and processed before being given to the patient. By receiving these enzyme replacements, the body is able to successfully perform the functions inhibited by the deficiency. The effectiveness of ERT varies from person to person and what is being treated, but in some cases it is the only available treatment option.
The global Enzyme Replacement Therapy (ERT) Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Enzyme Replacement Therapy (ERT) Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Enzyme Replacement Therapy (ERT) Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Enzyme Replacement Therapy (ERT) Drugs include Sanofi, Takeda, BioMarin, AbbVie, Alexion, Allergan, Horizon Pharma, Johnson & Johnson, Actelion, Recordati Rare Diseases, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Enzyme Replacement Therapy (ERT) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enzyme Replacement Therapy (ERT) Drugs.
The Enzyme Replacement Therapy (ERT) Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Enzyme Replacement Therapy (ERT) Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enzyme Replacement Therapy (ERT) Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Enzyme Replacement Therapy (ERT) Drugs Market Report

Report Metric Details
Report Name Enzyme Replacement Therapy (ERT) Drugs Market
Segment by Type
  • Oral Treatment
  • Injection Treatment
Segment by Application
  • Fabry Disease
  • Gaucher Disease
  • Pompe Disease
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi, Takeda, BioMarin, AbbVie, Alexion, Allergan, Horizon Pharma, Johnson & Johnson, Actelion, Recordati Rare Diseases, Pfizer, Digestive Care, Leadiant Biosciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Enzyme Replacement Therapy (ERT) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Enzyme Replacement Therapy (ERT) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Enzyme Replacement Therapy (ERT) Drugs Market report?

Ans: The main players in the Enzyme Replacement Therapy (ERT) Drugs Market are Sanofi, Takeda, BioMarin, AbbVie, Alexion, Allergan, Horizon Pharma, Johnson & Johnson, Actelion, Recordati Rare Diseases, Pfizer, Digestive Care, Leadiant Biosciences

What are the Application segmentation covered in the Enzyme Replacement Therapy (ERT) Drugs Market report?

Ans: The Applications covered in the Enzyme Replacement Therapy (ERT) Drugs Market report are Fabry Disease, Gaucher Disease, Pompe Disease, Other

What are the Type segmentation covered in the Enzyme Replacement Therapy (ERT) Drugs Market report?

Ans: The Types covered in the Enzyme Replacement Therapy (ERT) Drugs Market report are Oral Treatment, Injection Treatment

1 Enzyme Replacement Therapy (ERT) Drugs Market Overview
1.1 Product Definition
1.2 Enzyme Replacement Therapy (ERT) Drugs by Type
1.2.1 Global Enzyme Replacement Therapy (ERT) Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Oral Treatment
1.2.3 Injection Treatment
1.3 Enzyme Replacement Therapy (ERT) Drugs by Application
1.3.1 Global Enzyme Replacement Therapy (ERT) Drugs Market Value by Application (2024-2030)
1.3.2 Fabry Disease
1.3.3 Gaucher Disease
1.3.4 Pompe Disease
1.3.5 Other
1.4 Global Enzyme Replacement Therapy (ERT) Drugs Market Size Estimates and Forecasts
1.4.1 Global Enzyme Replacement Therapy (ERT) Drugs Revenue 2019-2030
1.4.2 Global Enzyme Replacement Therapy (ERT) Drugs Sales 2019-2030
1.4.3 Global Enzyme Replacement Therapy (ERT) Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Enzyme Replacement Therapy (ERT) Drugs Market Competition by Manufacturers
2.1 Global Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Enzyme Replacement Therapy (ERT) Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Enzyme Replacement Therapy (ERT) Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Enzyme Replacement Therapy (ERT) Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Enzyme Replacement Therapy (ERT) Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Enzyme Replacement Therapy (ERT) Drugs, Product Type & Application
2.7 Global Key Manufacturers of Enzyme Replacement Therapy (ERT) Drugs, Date of Enter into This Industry
2.8 Global Enzyme Replacement Therapy (ERT) Drugs Market Competitive Situation and Trends
2.8.1 Global Enzyme Replacement Therapy (ERT) Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Enzyme Replacement Therapy (ERT) Drugs Players Market Share by Revenue
2.8.3 Global Enzyme Replacement Therapy (ERT) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Enzyme Replacement Therapy (ERT) Drugs Market Scenario by Region
3.1 Global Enzyme Replacement Therapy (ERT) Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Enzyme Replacement Therapy (ERT) Drugs Sales by Region: 2019-2030
3.2.1 Global Enzyme Replacement Therapy (ERT) Drugs Sales by Region: 2019-2024
3.2.2 Global Enzyme Replacement Therapy (ERT) Drugs Sales by Region: 2025-2030
3.3 Global Enzyme Replacement Therapy (ERT) Drugs Revenue by Region: 2019-2030
3.3.1 Global Enzyme Replacement Therapy (ERT) Drugs Revenue by Region: 2019-2024
3.3.2 Global Enzyme Replacement Therapy (ERT) Drugs Revenue by Region: 2025-2030
3.4 North America Enzyme Replacement Therapy (ERT) Drugs Market Facts & Figures by Country
3.4.1 North America Enzyme Replacement Therapy (ERT) Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Enzyme Replacement Therapy (ERT) Drugs Sales by Country (2019-2030)
3.4.3 North America Enzyme Replacement Therapy (ERT) Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Enzyme Replacement Therapy (ERT) Drugs Market Facts & Figures by Country
3.5.1 Europe Enzyme Replacement Therapy (ERT) Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Enzyme Replacement Therapy (ERT) Drugs Sales by Country (2019-2030)
3.5.3 Europe Enzyme Replacement Therapy (ERT) Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Enzyme Replacement Therapy (ERT) Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Enzyme Replacement Therapy (ERT) Drugs Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Enzyme Replacement Therapy (ERT) Drugs Sales by Region (2019-2030)
3.6.3 Asia Pacific Enzyme Replacement Therapy (ERT) Drugs Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Enzyme Replacement Therapy (ERT) Drugs Market Facts & Figures by Country
3.7.1 Latin America Enzyme Replacement Therapy (ERT) Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Enzyme Replacement Therapy (ERT) Drugs Sales by Country (2019-2030)
3.7.3 Latin America Enzyme Replacement Therapy (ERT) Drugs Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Enzyme Replacement Therapy (ERT) Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Enzyme Replacement Therapy (ERT) Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Enzyme Replacement Therapy (ERT) Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Enzyme Replacement Therapy (ERT) Drugs Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Enzyme Replacement Therapy (ERT) Drugs Sales by Type (2019-2030)
4.1.1 Global Enzyme Replacement Therapy (ERT) Drugs Sales by Type (2019-2024)
4.1.2 Global Enzyme Replacement Therapy (ERT) Drugs Sales by Type (2025-2030)
4.1.3 Global Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Type (2019-2030)
4.2 Global Enzyme Replacement Therapy (ERT) Drugs Revenue by Type (2019-2030)
4.2.1 Global Enzyme Replacement Therapy (ERT) Drugs Revenue by Type (2019-2024)
4.2.2 Global Enzyme Replacement Therapy (ERT) Drugs Revenue by Type (2025-2030)
4.2.3 Global Enzyme Replacement Therapy (ERT) Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Enzyme Replacement Therapy (ERT) Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Enzyme Replacement Therapy (ERT) Drugs Sales by Application (2019-2030)
5.1.1 Global Enzyme Replacement Therapy (ERT) Drugs Sales by Application (2019-2024)
5.1.2 Global Enzyme Replacement Therapy (ERT) Drugs Sales by Application (2025-2030)
5.1.3 Global Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Application (2019-2030)
5.2 Global Enzyme Replacement Therapy (ERT) Drugs Revenue by Application (2019-2030)
5.2.1 Global Enzyme Replacement Therapy (ERT) Drugs Revenue by Application (2019-2024)
5.2.2 Global Enzyme Replacement Therapy (ERT) Drugs Revenue by Application (2025-2030)
5.2.3 Global Enzyme Replacement Therapy (ERT) Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Enzyme Replacement Therapy (ERT) Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Enzyme Replacement Therapy (ERT) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Enzyme Replacement Therapy (ERT) Drugs Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Takeda
6.2.1 Takeda Company Information
6.2.2 Takeda Description and Business Overview
6.2.3 Takeda Enzyme Replacement Therapy (ERT) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Takeda Enzyme Replacement Therapy (ERT) Drugs Product Portfolio
6.2.5 Takeda Recent Developments/Updates
6.3 BioMarin
6.3.1 BioMarin Company Information
6.3.2 BioMarin Description and Business Overview
6.3.3 BioMarin Enzyme Replacement Therapy (ERT) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 BioMarin Enzyme Replacement Therapy (ERT) Drugs Product Portfolio
6.3.5 BioMarin Recent Developments/Updates
6.4 AbbVie
6.4.1 AbbVie Company Information
6.4.2 AbbVie Description and Business Overview
6.4.3 AbbVie Enzyme Replacement Therapy (ERT) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AbbVie Enzyme Replacement Therapy (ERT) Drugs Product Portfolio
6.4.5 AbbVie Recent Developments/Updates
6.5 Alexion
6.5.1 Alexion Company Information
6.5.2 Alexion Description and Business Overview
6.5.3 Alexion Enzyme Replacement Therapy (ERT) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Alexion Enzyme Replacement Therapy (ERT) Drugs Product Portfolio
6.5.5 Alexion Recent Developments/Updates
6.6 Allergan
6.6.1 Allergan Company Information
6.6.2 Allergan Description and Business Overview
6.6.3 Allergan Enzyme Replacement Therapy (ERT) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Allergan Enzyme Replacement Therapy (ERT) Drugs Product Portfolio
6.6.5 Allergan Recent Developments/Updates
6.7 Horizon Pharma
6.7.1 Horizon Pharma Company Information
6.7.2 Horizon Pharma Description and Business Overview
6.7.3 Horizon Pharma Enzyme Replacement Therapy (ERT) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Horizon Pharma Enzyme Replacement Therapy (ERT) Drugs Product Portfolio
6.7.5 Horizon Pharma Recent Developments/Updates
6.8 Johnson & Johnson
6.8.1 Johnson & Johnson Company Information
6.8.2 Johnson & Johnson Description and Business Overview
6.8.3 Johnson & Johnson Enzyme Replacement Therapy (ERT) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Johnson & Johnson Enzyme Replacement Therapy (ERT) Drugs Product Portfolio
6.8.5 Johnson & Johnson Recent Developments/Updates
6.9 Actelion
6.9.1 Actelion Company Information
6.9.2 Actelion Description and Business Overview
6.9.3 Actelion Enzyme Replacement Therapy (ERT) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Actelion Enzyme Replacement Therapy (ERT) Drugs Product Portfolio
6.9.5 Actelion Recent Developments/Updates
6.10 Recordati Rare Diseases
6.10.1 Recordati Rare Diseases Company Information
6.10.2 Recordati Rare Diseases Description and Business Overview
6.10.3 Recordati Rare Diseases Enzyme Replacement Therapy (ERT) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Recordati Rare Diseases Enzyme Replacement Therapy (ERT) Drugs Product Portfolio
6.10.5 Recordati Rare Diseases Recent Developments/Updates
6.11 Pfizer
6.11.1 Pfizer Company Information
6.11.2 Pfizer Description and Business Overview
6.11.3 Pfizer Enzyme Replacement Therapy (ERT) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Pfizer Enzyme Replacement Therapy (ERT) Drugs Product Portfolio
6.11.5 Pfizer Recent Developments/Updates
6.12 Digestive Care
6.12.1 Digestive Care Company Information
6.12.2 Digestive Care Description and Business Overview
6.12.3 Digestive Care Enzyme Replacement Therapy (ERT) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Digestive Care Enzyme Replacement Therapy (ERT) Drugs Product Portfolio
6.12.5 Digestive Care Recent Developments/Updates
6.13 Leadiant Biosciences
6.13.1 Leadiant Biosciences Company Information
6.13.2 Leadiant Biosciences Description and Business Overview
6.13.3 Leadiant Biosciences Enzyme Replacement Therapy (ERT) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Leadiant Biosciences Enzyme Replacement Therapy (ERT) Drugs Product Portfolio
6.13.5 Leadiant Biosciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Enzyme Replacement Therapy (ERT) Drugs Industry Chain Analysis
7.2 Enzyme Replacement Therapy (ERT) Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Enzyme Replacement Therapy (ERT) Drugs Production Mode & Process
7.4 Enzyme Replacement Therapy (ERT) Drugs Sales and Marketing
7.4.1 Enzyme Replacement Therapy (ERT) Drugs Sales Channels
7.4.2 Enzyme Replacement Therapy (ERT) Drugs Distributors
7.5 Enzyme Replacement Therapy (ERT) Drugs Customers
8 Enzyme Replacement Therapy (ERT) Drugs Market Dynamics
8.1 Enzyme Replacement Therapy (ERT) Drugs Industry Trends
8.2 Enzyme Replacement Therapy (ERT) Drugs Market Drivers
8.3 Enzyme Replacement Therapy (ERT) Drugs Market Challenges
8.4 Enzyme Replacement Therapy (ERT) Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
ERT
Sanofi
Takeda
BioMarin
AbbVie
Alexion
Allergan plc
Horizon Pharma
Johnson & Johnson
Actelion Ltd
Recordati Rare Diseases
Pfizer Inc
Digestive Care
Leadiant Biosciences
List of Tables
 Table 1. Global Enzyme Replacement Therapy (ERT) Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Enzyme Replacement Therapy (ERT) Drugs Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Enzyme Replacement Therapy (ERT) Drugs Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Enzyme Replacement Therapy (ERT) Drugs Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Enzyme Replacement Therapy (ERT) Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Enzyme Replacement Therapy (ERT) Drugs Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Enzyme Replacement Therapy (ERT) Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Enzyme Replacement Therapy (ERT) Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Enzyme Replacement Therapy (ERT) Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Enzyme Replacement Therapy (ERT) Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Enzyme Replacement Therapy (ERT) Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Enzyme Replacement Therapy (ERT) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enzyme Replacement Therapy (ERT) Drugs as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Enzyme Replacement Therapy (ERT) Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Enzyme Replacement Therapy (ERT) Drugs Sales by Region (2019-2024) & (K Units)
 Table 18. Global Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Region (2019-2024)
 Table 19. Global Enzyme Replacement Therapy (ERT) Drugs Sales by Region (2025-2030) & (K Units)
 Table 20. Global Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Region (2025-2030)
 Table 21. Global Enzyme Replacement Therapy (ERT) Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Enzyme Replacement Therapy (ERT) Drugs Revenue Market Share by Region (2019-2024)
 Table 23. Global Enzyme Replacement Therapy (ERT) Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Enzyme Replacement Therapy (ERT) Drugs Revenue Market Share by Region (2025-2030)
 Table 25. North America Enzyme Replacement Therapy (ERT) Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Enzyme Replacement Therapy (ERT) Drugs Sales by Country (2019-2024) & (K Units)
 Table 27. North America Enzyme Replacement Therapy (ERT) Drugs Sales by Country (2025-2030) & (K Units)
 Table 28. North America Enzyme Replacement Therapy (ERT) Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Enzyme Replacement Therapy (ERT) Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Enzyme Replacement Therapy (ERT) Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Enzyme Replacement Therapy (ERT) Drugs Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Enzyme Replacement Therapy (ERT) Drugs Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Enzyme Replacement Therapy (ERT) Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Enzyme Replacement Therapy (ERT) Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Enzyme Replacement Therapy (ERT) Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Enzyme Replacement Therapy (ERT) Drugs Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Enzyme Replacement Therapy (ERT) Drugs Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Enzyme Replacement Therapy (ERT) Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Enzyme Replacement Therapy (ERT) Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Enzyme Replacement Therapy (ERT) Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Enzyme Replacement Therapy (ERT) Drugs Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Enzyme Replacement Therapy (ERT) Drugs Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Enzyme Replacement Therapy (ERT) Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Enzyme Replacement Therapy (ERT) Drugs Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Enzyme Replacement Therapy (ERT) Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Enzyme Replacement Therapy (ERT) Drugs Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Enzyme Replacement Therapy (ERT) Drugs Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Enzyme Replacement Therapy (ERT) Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Enzyme Replacement Therapy (ERT) Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Enzyme Replacement Therapy (ERT) Drugs Sales (K Units) by Type (2019-2024)
 Table 51. Global Enzyme Replacement Therapy (ERT) Drugs Sales (K Units) by Type (2025-2030)
 Table 52. Global Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Type (2019-2024)
 Table 53. Global Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Type (2025-2030)
 Table 54. Global Enzyme Replacement Therapy (ERT) Drugs Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Enzyme Replacement Therapy (ERT) Drugs Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Enzyme Replacement Therapy (ERT) Drugs Revenue Market Share by Type (2019-2024)
 Table 57. Global Enzyme Replacement Therapy (ERT) Drugs Revenue Market Share by Type (2025-2030)
 Table 58. Global Enzyme Replacement Therapy (ERT) Drugs Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Enzyme Replacement Therapy (ERT) Drugs Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Enzyme Replacement Therapy (ERT) Drugs Sales (K Units) by Application (2019-2024)
 Table 61. Global Enzyme Replacement Therapy (ERT) Drugs Sales (K Units) by Application (2025-2030)
 Table 62. Global Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Application (2019-2024)
 Table 63. Global Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Application (2025-2030)
 Table 64. Global Enzyme Replacement Therapy (ERT) Drugs Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Enzyme Replacement Therapy (ERT) Drugs Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Enzyme Replacement Therapy (ERT) Drugs Revenue Market Share by Application (2019-2024)
 Table 67. Global Enzyme Replacement Therapy (ERT) Drugs Revenue Market Share by Application (2025-2030)
 Table 68. Global Enzyme Replacement Therapy (ERT) Drugs Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Enzyme Replacement Therapy (ERT) Drugs Price (US$/Unit) by Application (2025-2030)
 Table 70. Sanofi Company Information
 Table 71. Sanofi Description and Business Overview
 Table 72. Sanofi Enzyme Replacement Therapy (ERT) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Sanofi Enzyme Replacement Therapy (ERT) Drugs Product
 Table 74. Sanofi Recent Developments/Updates
 Table 75. Takeda Company Information
 Table 76. Takeda Description and Business Overview
 Table 77. Takeda Enzyme Replacement Therapy (ERT) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Takeda Enzyme Replacement Therapy (ERT) Drugs Product
 Table 79. Takeda Recent Developments/Updates
 Table 80. BioMarin Company Information
 Table 81. BioMarin Description and Business Overview
 Table 82. BioMarin Enzyme Replacement Therapy (ERT) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. BioMarin Enzyme Replacement Therapy (ERT) Drugs Product
 Table 84. BioMarin Recent Developments/Updates
 Table 85. AbbVie Company Information
 Table 86. AbbVie Description and Business Overview
 Table 87. AbbVie Enzyme Replacement Therapy (ERT) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. AbbVie Enzyme Replacement Therapy (ERT) Drugs Product
 Table 89. AbbVie Recent Developments/Updates
 Table 90. Alexion Company Information
 Table 91. Alexion Description and Business Overview
 Table 92. Alexion Enzyme Replacement Therapy (ERT) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Alexion Enzyme Replacement Therapy (ERT) Drugs Product
 Table 94. Alexion Recent Developments/Updates
 Table 95. Allergan Company Information
 Table 96. Allergan Description and Business Overview
 Table 97. Allergan Enzyme Replacement Therapy (ERT) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Allergan Enzyme Replacement Therapy (ERT) Drugs Product
 Table 99. Allergan Recent Developments/Updates
 Table 100. Horizon Pharma Company Information
 Table 101. Horizon Pharma Description and Business Overview
 Table 102. Horizon Pharma Enzyme Replacement Therapy (ERT) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Horizon Pharma Enzyme Replacement Therapy (ERT) Drugs Product
 Table 104. Horizon Pharma Recent Developments/Updates
 Table 105. Johnson & Johnson Company Information
 Table 106. Johnson & Johnson Description and Business Overview
 Table 107. Johnson & Johnson Enzyme Replacement Therapy (ERT) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Johnson & Johnson Enzyme Replacement Therapy (ERT) Drugs Product
 Table 109. Johnson & Johnson Recent Developments/Updates
 Table 110. Actelion Company Information
 Table 111. Actelion Description and Business Overview
 Table 112. Actelion Enzyme Replacement Therapy (ERT) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Actelion Enzyme Replacement Therapy (ERT) Drugs Product
 Table 114. Actelion Recent Developments/Updates
 Table 115. Recordati Rare Diseases Company Information
 Table 116. Recordati Rare Diseases Description and Business Overview
 Table 117. Recordati Rare Diseases Enzyme Replacement Therapy (ERT) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Recordati Rare Diseases Enzyme Replacement Therapy (ERT) Drugs Product
 Table 119. Recordati Rare Diseases Recent Developments/Updates
 Table 120. Pfizer Company Information
 Table 121. Pfizer Description and Business Overview
 Table 122. Pfizer Enzyme Replacement Therapy (ERT) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Pfizer Enzyme Replacement Therapy (ERT) Drugs Product
 Table 124. Pfizer Recent Developments/Updates
 Table 125. Digestive Care Company Information
 Table 126. Digestive Care Description and Business Overview
 Table 127. Digestive Care Enzyme Replacement Therapy (ERT) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. Digestive Care Enzyme Replacement Therapy (ERT) Drugs Product
 Table 129. Digestive Care Recent Developments/Updates
 Table 130. Leadiant Biosciences Company Information
 Table 131. Leadiant Biosciences Description and Business Overview
 Table 132. Leadiant Biosciences Enzyme Replacement Therapy (ERT) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 133. Leadiant Biosciences Enzyme Replacement Therapy (ERT) Drugs Product
 Table 134. Leadiant Biosciences Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Enzyme Replacement Therapy (ERT) Drugs Distributors List
 Table 138. Enzyme Replacement Therapy (ERT) Drugs Customers List
 Table 139. Enzyme Replacement Therapy (ERT) Drugs Market Trends
 Table 140. Enzyme Replacement Therapy (ERT) Drugs Market Drivers
 Table 141. Enzyme Replacement Therapy (ERT) Drugs Market Challenges
 Table 142. Enzyme Replacement Therapy (ERT) Drugs Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Enzyme Replacement Therapy (ERT) Drugs
 Figure 2. Global Enzyme Replacement Therapy (ERT) Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Enzyme Replacement Therapy (ERT) Drugs Market Share by Type: 2023 & 2030
 Figure 4. Oral Treatment Product Picture
 Figure 5. Injection Treatment Product Picture
 Figure 6. Global Enzyme Replacement Therapy (ERT) Drugs Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Enzyme Replacement Therapy (ERT) Drugs Market Share by Application: 2023 & 2030
 Figure 8. Fabry Disease
 Figure 9. Gaucher Disease
 Figure 10. Pompe Disease
 Figure 11. Other
 Figure 12. Global Enzyme Replacement Therapy (ERT) Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Enzyme Replacement Therapy (ERT) Drugs Market Size (2019-2030) & (US$ Million)
 Figure 14. Global Enzyme Replacement Therapy (ERT) Drugs Sales (2019-2030) & (K Units)
 Figure 15. Global Enzyme Replacement Therapy (ERT) Drugs Average Price (US$/Unit) & (2019-2030)
 Figure 16. Enzyme Replacement Therapy (ERT) Drugs Report Years Considered
 Figure 17. Enzyme Replacement Therapy (ERT) Drugs Sales Share by Manufacturers in 2023
 Figure 18. Global Enzyme Replacement Therapy (ERT) Drugs Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest Enzyme Replacement Therapy (ERT) Drugs Players: Market Share by Revenue in Enzyme Replacement Therapy (ERT) Drugs in 2023
 Figure 20. Enzyme Replacement Therapy (ERT) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global Enzyme Replacement Therapy (ERT) Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Country (2019-2030)
 Figure 23. North America Enzyme Replacement Therapy (ERT) Drugs Revenue Market Share by Country (2019-2030)
 Figure 24. United States Enzyme Replacement Therapy (ERT) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada Enzyme Replacement Therapy (ERT) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Country (2019-2030)
 Figure 27. Europe Enzyme Replacement Therapy (ERT) Drugs Revenue Market Share by Country (2019-2030)
 Figure 28. Germany Enzyme Replacement Therapy (ERT) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France Enzyme Replacement Therapy (ERT) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. Enzyme Replacement Therapy (ERT) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy Enzyme Replacement Therapy (ERT) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia Enzyme Replacement Therapy (ERT) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific Enzyme Replacement Therapy (ERT) Drugs Revenue Market Share by Region (2019-2030)
 Figure 35. China Enzyme Replacement Therapy (ERT) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan Enzyme Replacement Therapy (ERT) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea Enzyme Replacement Therapy (ERT) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India Enzyme Replacement Therapy (ERT) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia Enzyme Replacement Therapy (ERT) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan Enzyme Replacement Therapy (ERT) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia Enzyme Replacement Therapy (ERT) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Country (2019-2030)
 Figure 43. Mexico Enzyme Replacement Therapy (ERT) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil Enzyme Replacement Therapy (ERT) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina Enzyme Replacement Therapy (ERT) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia Enzyme Replacement Therapy (ERT) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa Enzyme Replacement Therapy (ERT) Drugs Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa Enzyme Replacement Therapy (ERT) Drugs Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey Enzyme Replacement Therapy (ERT) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia Enzyme Replacement Therapy (ERT) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE Enzyme Replacement Therapy (ERT) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of Enzyme Replacement Therapy (ERT) Drugs by Type (2019-2030)
 Figure 53. Global Revenue Market Share of Enzyme Replacement Therapy (ERT) Drugs by Type (2019-2030)
 Figure 54. Global Enzyme Replacement Therapy (ERT) Drugs Price (US$/Unit) by Type (2019-2030)
 Figure 55. Global Sales Market Share of Enzyme Replacement Therapy (ERT) Drugs by Application (2019-2030)
 Figure 56. Global Revenue Market Share of Enzyme Replacement Therapy (ERT) Drugs by Application (2019-2030)
 Figure 57. Global Enzyme Replacement Therapy (ERT) Drugs Price (US$/Unit) by Application (2019-2030)
 Figure 58. Enzyme Replacement Therapy (ERT) Drugs Value Chain
 Figure 59. Enzyme Replacement Therapy (ERT) Drugs Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Enzyme Replacement Therapy Market Research Report 2025
Global Enzyme Replacement Therapy Drugs for Gaucher Disease Market Research Report 2024
Gaucher and Pompe Diseases Enzyme Replacement Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gaucher and Pompe Diseases Enzyme Replacement Therapy ERT Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rare Disease Enzyme Replacement Therapy Drugs Market Research Report 2024
Estrogen Replacement Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Type 1 Gaucher Disease Treatment Market Research Report 2024
Global Renal Replacement and ESRD Therapy Market Research Report 2025
Global Renal Replacement and End Stage Renal Disease Therapy Market Research Report 2025
Global Renal Replacement Therapeutics Market Research Report 2025
Global Renal Replacement Therapy Market Research Report 2025
Global Enzyme Product Market Research Report 2025
Global Intraoperative Ultrasound Market Insights Forecast to 2030
Therapeutic Enzyme Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Therapeutic Enzymes Market Insights Forecast to 2030
Global Protein based Drug Market Research Report 2024
Global Gene Transplant Market Research Report 2024
Global Alternate site Infusion Therapy Market Insights Forecast to 2030
Global Gene Therapy Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Mesenchymal Stem Cell Therapy MSCT Market Research Report 2025

RELATED REPORTS

Global Disposable Laparoscopic Dissector Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28P19620
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Neurosurgery Surgical Instruments Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14F16814
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Disposable Laparoscopic Grasping Forceps Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16C19880
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Activated Prothrombin Complex Concentrate (aPCC) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0O17020
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions